IDEXX LABORATORIES INC /DE — Director's Dealing 2015

Mar 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-03-04

Reporting Person: POWERS JOHNNY D (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-04	Common Stock	M	2372	$34.37	Acquired	13267	Direct
2015-03-04	Common Stock	M	2000	$53.31	Acquired	15267	Direct
2015-03-04	Common Stock	S	6168	$158.4937	Disposed	9099	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-04	Non-Qualified Stock Option (right to buy)	$34.37	M	2372	Disposed	2016-02-13	Common Stock (2372)	Direct
2015-03-04	Non-Qualified Stock Option (right to buy)	$53.31	M	2000	Disposed	2017-02-13	Common Stock (2000)	Direct

Footnotes

F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $158.4650 to $158.5750, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,373 shares on 02/14/2010, 02/14/2011, 02/14/2012 and 02/14/2013, and the remaining 2,372 shares on 02/14/2014.

F3: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014, and the remaining 1,733 shares on 02/14/2015.